Skip to main content
Clinical Trials/NCT04532216
NCT04532216
Unknown
Not Applicable

The Clinical and Biomechanical Research of the New Arthroscopic Technique for the Treatment of High-grade Dislocation of the Acromioclavicular Joint

Beijing Jishuitan Hospital0 sites54 target enrollmentSeptember 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Dislocation of the Acromioclavicular Joint
Sponsor
Beijing Jishuitan Hospital
Enrollment
54
Primary Endpoint
ASES score
Last Updated
5 years ago

Overview

Brief Summary

Acromioclavicular joint dislocation is a common disease in shoulder surgery, which mostly occurs in young and middle-aged patients. Severe acromioclavicular joint dislocations of Rockwood type IV, V, and VI require surgical treatment. Among them, the common clinical type IV and type V severe acromioclavicular joint dislocations are often treated with autologous/allogenous tendon transplantation and coracoclavicular ligament reconstruction under shoulder arthroscopy. Although this minimally invasive surgical method has certain advantages over incision surgery, due to factors such as poor healing after tendon transplantation and failure of coracoclavicular fixation, the recurrence rate of postoperative dislocation is still as high as 30%, which seriously affects the prognosis of patients. Therefore, we proposed a new surgical technique of minimally invasive shoulder arthroscopic coracoclavicular suspension fixation and coracoclavicular ligament residual reconstruction, which aims to strengthen the fixation strength of the coracoclavicular space, promote the healing of the coracoclavicular ligament, and reduce the recurrence rate of postoperative dislocation. To improve postoperative shoulder joint function of patients. This project intends to use non-randomized controlled clinical research and biomechanical research to compare traditional surgical techniques with new microscopic techniques in terms of surgical efficacy, postoperative complications, and internal plant fixation strength to establish the therapeutic advantages of the new technology. Its application and promotion provide important clinical evidence to improve the treatment of severe acromioclavicular joint dislocation in the field of shoulder surgery.

Registry
clinicaltrials.gov
Start Date
September 1, 2020
End Date
June 30, 2023
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Chunyan Jiang

Director of Sports Medicine Service of Beijing Jishuitan hospital

Beijing Jishuitan Hospital

Eligibility Criteria

Inclusion Criteria

  • Consecutive cases of coracoclavicular ligament reconstruction surgery usingTightRope Device With Allograft Augmentation and shoulder arthroscopic reconstruction of coracoclavicular ligament with autologous/allogeneic tendon transplantation.
  • Injury type Rockwood type IV and V type severe acromioclavicular joint dislocation
  • The time from injury to operation is less than 3 weeks

Exclusion Criteria

  • Combined with neurovascular injury
  • Previous history of ipsilateral shoulder surgery
  • The patient refused to sign the informed consent and participate in the trial

Outcomes

Primary Outcomes

ASES score

Time Frame: 1 year postoperatively

The ASES score is a 10-item measure of shoulder pain and function

Similar Trials